Wird geladen...

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer

Breast cancer is the most common cancer in women, with 1.7 million new cases each year. As early diagnosis and prognosis are crucial factors in cancer treatment, we investigated potential DNA methylation biomarkers of the tumour suppressor family Ras-association domain family (RASSF). Promoter hyper...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Richter, Antje M., Walesch, Sara K., Dammann, Reinhard H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4810110/
https://ncbi.nlm.nih.gov/pubmed/26927176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers8030026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!